206 related articles for article (PubMed ID: 27829047)
1. Immunohistochemical Typing of Adenocarcinomas of the Pancreatobiliary System Improves Diagnosis and Prognostic Stratification.
Fernández Moro C; Fernandez-Woodbridge A; Alistair D'souza M; Zhang Q; Bozoky B; Kandaswamy SV; Catalano P; Heuchel R; Shtembari S; Del Chiaro M; Danielsson O; Björnstedt M; Löhr JM; Isaksson B; Verbeke C; Bozóky B
PLoS One; 2016; 11(11):e0166067. PubMed ID: 27829047
[TBL] [Abstract][Full Text] [Related]
2. Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas.
Perysinakis I; Minaidou E; Leontara V; Mantas D; Sotiropoulos GC; Tsipras H; Zografos GN; Margaris I; Kouraklis G
Int J Surg Pathol; 2017 Feb; 25(1):31-40. PubMed ID: 27543509
[TBL] [Abstract][Full Text] [Related]
3. Differentiation and prognostic markers in ampullary cancer: Role of p53, MDM2, CDX2, mucins and cytokeratins.
Perysinakis I; Minaidou E; Mantas D; Sotiropoulos GC; Leontara V; Tsipras H; Zografos GN; Margaris I; Kouraklis G
Pathol Res Pract; 2016 Nov; 212(11):1039-1047. PubMed ID: 27688085
[TBL] [Abstract][Full Text] [Related]
4. Annexin A10 is an immunohistochemical marker for adenocarcinoma of the upper gastrointestinal tract and pancreatobiliary system.
Lu SH; Yuan RH; Chen YL; Hsu HC; Jeng YM
Histopathology; 2013 Nov; 63(5):640-8. PubMed ID: 24024557
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and treatment predictive significance of SATB1 and SATB2 expression in pancreatic and periampullary adenocarcinoma.
Elebro J; Heby M; Gaber A; Nodin B; Jonsson L; Fristedt R; Uhlén M; Jirström K; Eberhard J
J Transl Med; 2014 Oct; 12():289. PubMed ID: 25323550
[TBL] [Abstract][Full Text] [Related]
6. Molecular signatures of mRNAs and miRNAs as prognostic biomarkers in pancreatobiliary and intestinal types of periampullary adenocarcinomas.
Sandhu V; Bowitz Lothe IM; Labori KJ; Lingjærde OC; Buanes T; Dalsgaard AM; Skrede ML; Hamfjord J; Haaland T; Eide TJ; Børresen-Dale AL; Ikdahl T; Kure EH
Mol Oncol; 2015 Apr; 9(4):758-71. PubMed ID: 25579086
[TBL] [Abstract][Full Text] [Related]
7. Utility of immunohistochemistry in the pancreatobiliary tract.
Lin F; Chen ZE; Wang HL
Arch Pathol Lab Med; 2015 Jan; 139(1):24-38. PubMed ID: 25549142
[TBL] [Abstract][Full Text] [Related]
8. Intestinal and pancreatobiliary differentiation in periampullary carcinoma: the role of immunohistochemistry.
Kumari N; Prabha K; Singh RK; Baitha DK; Krishnani N
Hum Pathol; 2013 Oct; 44(10):2213-9. PubMed ID: 23834763
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of pancreatobiliary-type from intestinal-type periampullary carcinomas using 3.0T MRI.
Bi L; Dong Y; Jing C; Wu Q; Xiu J; Cai S; Huang Z; Zhang J; Han X; Liu Q; Lv S
J Magn Reson Imaging; 2016 Apr; 43(4):877-86. PubMed ID: 26395453
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical Markers Distinguishing Cholangiocellular Carcinoma (CCC) from Pancreatic Ductal Adenocarcinoma (PDAC) Discovered by Proteomic Analysis of Microdissected Cells.
Padden J; Ahrens M; Kälsch J; Bertram S; Megger DA; Bracht T; Eisenacher M; Kocabayoglu P; Meyer HE; Sipos B; Baba HA; Sitek B
Mol Cell Proteomics; 2016 Mar; 15(3):1072-82. PubMed ID: 26644413
[TBL] [Abstract][Full Text] [Related]
11. An Optimized Set of Fluorescence In Situ Hybridization Probes for Detection of Pancreatobiliary Tract Cancer in Cytology Brush Samples.
Barr Fritcher EG; Voss JS; Brankley SM; Campion MB; Jenkins SM; Keeney ME; Henry MR; Kerr SM; Chaiteerakij R; Pestova EV; Clayton AC; Zhang J; Roberts LR; Gores GJ; Halling KC; Kipp BR
Gastroenterology; 2015 Dec; 149(7):1813-1824.e1. PubMed ID: 26327129
[TBL] [Abstract][Full Text] [Related]
12. Does HepPar-1 immunoexpression have a role in differential diagnosis of periampullary cancer?
Gulluoglu MG; Karayigit E; Ozden I; Kapran Y; Dizdaroglu F
Pathology; 2008 Jan; 40(1):35-41. PubMed ID: 18038313
[TBL] [Abstract][Full Text] [Related]
13. Differentiation markers in pancreatic head adenocarcinomas: MUC1 and MUC4 expression indicates poor prognosis in pancreatobiliary differentiated tumours.
Westgaard A; Schjølberg AR; Cvancarova M; Eide TJ; Clausen OP; Gladhaug IP
Histopathology; 2009 Feb; 54(3):337-47. PubMed ID: 19236510
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical Predictors for Intestinal and Pancreatobiliary Types of Adenocarcinoma of The Ampulla of Vater.
da Silveira Santos JPL; Machado CJ; Junior EP; Rodrigues JBSR; Vidigal PT; Resende V
J Gastrointest Surg; 2018 Jul; 22(7):1171-1178. PubMed ID: 29736668
[TBL] [Abstract][Full Text] [Related]
15. Recent Updates on Neuroendocrine Tumors From the Gastrointestinal and Pancreatobiliary Tracts.
Kim JY; Hong SM
Arch Pathol Lab Med; 2016 May; 140(5):437-48. PubMed ID: 27128301
[TBL] [Abstract][Full Text] [Related]
16. T-complex-associated-testis-expressed 3 (TCTE3) is a novel marker for pancreatobiliary carcinomas.
Zhao CL; Hui Y; Wang LJ; Lombardo K; Yang D; Mangray S; Yakirevich E; Amin A; Huang CK; Lu S
Hum Pathol; 2017 Dec; 70():62-69. PubMed ID: 29079176
[TBL] [Abstract][Full Text] [Related]
17. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
[TBL] [Abstract][Full Text] [Related]
18. Multimodal data analysis reveals that pancreatobiliary-type ampullary adenocarcinoma resembles pancreatic adenocarcinoma and differs from cholangiocarcinoma.
Cheng J; Mao Y; Hong W; Hu W; Shu P; Huang K; Yu J; Jiang M; Li L; Wang W; Ni D; Li S
J Transl Med; 2022 Jun; 20(1):272. PubMed ID: 35705951
[TBL] [Abstract][Full Text] [Related]
19. Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?
Westgaard A; Pomianowska E; Clausen OP; Gladhaug IP
Ann Surg Oncol; 2013 Feb; 20(2):430-9. PubMed ID: 22956064
[TBL] [Abstract][Full Text] [Related]
20. Prognostic effect of hENT1, dCK and HuR expression by morphological type in periampullary adenocarcinoma, including pancreatic cancer.
Elebro J; Ben Dror L; Heby M; Nodin B; Jirström K; Eberhard J
Acta Oncol; 2016; 55(3):286-96. PubMed ID: 26362587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]